Wall 
NVS - Novartis
Annual data, 1998 to 2026, in US$ millions.
Last updated: Oct 3, 2026
Capital
Dividend
Revenue
Income
Asset
Equity
Rolling CAGR% per year, window ending each year
Other companies
AstraZeneca
Data since 1996
Amgen
Data since 1996
Roche
Data since 1998
Merck
Data since 1996
Gilead Sciences
Data since 1996
Novo Nordisk
Data since 1996
Pfizer
Data since 1996
Vertex Pharmaceuticals
Data since 1996
Bristol-Myers Squibb
Data since 1996
Sanofi
Data since 2001
GSK plc
Data since 1996
WuXi AppTec
Data since 2014
Moderna
Data since 2016
Regeneron Pharmaceuticals
Data since 1996
AbbVie
Data since 2010
Johnson & Johnson
Data since 1996
Eli Lilly
Data since 1996
Thermo Fisher Scientific
Data since 1996
CVS Health
Data since 1996
Texas Instruments
Data since 1996
KLA
Data since 1996
Royal Bank Of Canada
Data since 1996
Alibaba
Data since 2006
GE Vernova
Data since 2022
Goldman Sachs
Data since 1999
Shell
Data since 2001
Arista Networks
Data since 2012
CrowdStrike
Data since 2018
Mitsubishi UFJ Financial
Data since 1996
Netflix
Data since 2001
2026 is partial: Capital is the current value; Revenue and Income are TTM; Asset and Equity are the latest quarter reported. CAGR runs through 2026. Rolling CAGR needs positive values at both ends of the window. Dividend = yield × Capital (approximate). Orange bars mark years that fell from the prior year. Y axes are log scale, so zero or negative values are not shown.